Abstract
The article on topical application of cytotoxic drugs (July 5, 1968, p. 55) stated that demecolcine, methotrexate and 5-fluouracil had been used in concentrations ranging from 0.1% to 20%. This was in no way a recommendation, but we should like to make it clear that Ciba advise caution in the use of extemporaneously prepared ointments containing demecolcine, especially in concentrations greater than 0.5%. Lederle advise that local applications of methotrexate should contain no more than 1%. 5-Fluouracil should not be used at a concentration greater than 5%.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
